Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
70 1.4% |
 |
Gilead SciencesGILD |
55 1.9% |
 |
Catalyst PharmaceuticalsCPRX |
67 33% |
 |
Anavex Life SciencesAVXL |
0 0% |
 |
BridgeBio PharmaBBIO |
84 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Sep 2025 | 23 | |
| Aug 2025 | 23 | |
| Jul 2025 | 23 | |
| Jun 2025 | 23 |
How do employees feel about the future at Inovio Pharmaceuticals?
According to employees, the Business Outlook at Inovio Pharmaceuticals is highly negative. This is reflected in the average rating of 27 out of 100, which is considered very low. But this rating (aggregated from the top review sites in the US) is up by 17.4% since the previous month.
Analyzing Business Outlook, how is Inovio Pharmaceuticals performing compared to its industry peers?
Inovio Pharmaceuticals underperforms its industry peers when it comes to Business Outlook, ranking in the 27th percentile.
How has the business outlook at Inovio Pharmaceuticals changed over the last couple of months
In recent months, Inovio Pharmaceuticals' employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at Inovio Pharmaceuticals?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Inovio Pharmaceuticals.
